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The review is devoted to the analysis of structural and functional properties of molecular chaperon Hsp90.
Hsp90 is a representative of highly widespread family of heat shock proteins. The protein is found in
eubacteria and all branches of eukarya, but it is appa- rently absent in archaea. It is one of key regulators of
numerous signalling pathways, cell growth and development, apoptosis, induction of autoimmunity, and
progression of heart failure. The full functional activity of Hsp90 shows up in a complex with other
molecular chaperones and co-chaperones. Molecular interactions between chaperones, different signalling 
proteins and protein- partners are highly crucial for the normal functioning of signalling pathways and
their destruction causes an alteration in the cell physiology up to its death.
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In tro duc tion. When var i ous phys i cal and chem i cal
fac tors af fect the cells, their most fre quent tar get are
pro teins; they dam age the pro teins struc ture and
change their func tions. In or der to cope with pro tein
dam age the cells should ac ti vate a mech a nism of spe -
cific de fence. The in ves ti ga tion on the pro cesses of
cell func tion ing and fold ing of pro teins in vivo re -
vealed a se ries of cell com po nents, in volved ei ther in
the ca tal y sis of pro tein fold ing or in the reg u la tion of
dis tri bu tion of newly syn the sized pro teins among al -
ter na tive path ways of fold ing and ag gre ga tion [1].
Ellis [2] for mu lated an as sump tion that though pro tein 
fold ing is a spon ta ne ous pro cess there are crit i cal
stages, at which the par tic i pa tion of cell fac tors may
be cru cial. The role of these fac tors, called mo lec u lar
chaperones, con sists in pro vid ing op ti mal con di tions
for the pro cess of pro tein fold ing via re moval of “hin -
drances” or “in ad e quate con tacts”, which re sults in
pre ven tion of non-spe cific ag gre ga tion of pro teins,
syn the sized anew, and pro vid ing a trans port of these
pro teins to those intracellular com part ments, where
they are usu ally lo cal ized and func tion. The fact that
chaperones act as traf fic con trol lers is also sup ple -
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mented by their par tic i pa tion in pen e tra tion of pro -
teins through mem branes.
Chaperones are a part of a large fam ily of heat
shock pro teins (hsp), the syn the sis of which in the cell
is con sid er ably in creased in re sponse to heat shock or
other kinds of cell stress. At the same time most pro -
teins of this fam ily are syn the sized rather in ten sively
even at nor mal con di tions [1].
Mo lec u lar chap eron Hsp90 be longs to a widely
spread fam ily of heat shock pro teins; they were found
in eubacteria and all branches of eukarya, but they are
ap par ently ab sent in archaea [3]. Hsp90 is one of mo -
lec u lar chaperones, which is abun dantly pres ent in the 
cell at nor mal con di tions. Bac te rial chaperone is
known as HtpG. A hu man cell con tains four isoforms
of chaperones: cy to plas mic form Hsp90β, syn the -
sized con sti tu tively in the cells, and in duc ible form –
Hsp90α; Hsp90 an a logue – GRP94, the ex pres sion of
which is reg u lated by glu cose – was found in
endoplasmic re tic u lum; and mi to chon drial
TRAP1/hsp75 [3]. Forms Hsp90α and β are 85%
iden ti cal in their amino acid con tent which may be ex -
plained by du pli ca tion of genes more than 300 mil lion 
years ago. There is a high homology among Hsp90 of
lower eukaryotes, hu mans, and prokaryotes: the iden -
tity of Hsp82 of yeast to hu man Hsp90α and HtpG is
60% and 34%, re spec tively [4].
Hsp90 struc ture. The crys tal struc ture of a
full-length pro tein Hsp90 was de scribed about 10
years ago [4]. At the same time qual i ta tive crys tals of
a full-sized pro tein Hsp90, suit able for X-ray struc -
tural anal y sis, are yet to be stud ied, there are crys tals
of spe cific do mains. Hsp90 pro tein is a dimer of two
iden ti cal sub units. Each mono mer has three in de pend -
ent do mains: from highly con ser va tive ≈ 25 kDa
N-ter mi nal do main; ≈ 40 kDa M-do main, and ≈ 12
kDa C-ter mi nal do main [5] (Fig. 1). N-ter mi nal do -
main is con nected to M- and C-re gion via so called
charged linker which is vari able by both its con tent
and length in dif fer ent types and isoforms of the pro -
tein. The charged linker is not es sen tial for Hsp90
func tion and is en tirely ab sent in Hsp75/TRAP1 and
HtpG [6].
N-ter mi nal do main. The firs sig nif i cant prog ress
in the study on Hsp90 struc ture was the de ter mi na tion
of N-ter mi nal do main by lim ited pro te ol y sis [5]. The
in ves ti ga tion of the do main crys tal struc ture of hu man 
and yeast Hsp90 re vealed that it has a two-layer
αβ-sand wich struc ture [7] with a densely folded
anti-par al lel β-layer, con sist ing of eight stripes,
closed by nine α-coils on one side. There is a deep
pocket, formed by ATP/ADP-bind ing site, in the cen -
tre of α-coil part. This pocket in N-do main of hu man
Hsp90 was re vealed to be an oblig a tory site of bind ing 
geldanamycin (GA) which pre vents Hsp9 form ing
com plexes with pro tein kinase and ste roid hor mone
re cep tors [8]. The true func tion of N-do main and its
pocket be came ev i dent only by the com par i son of
amino acid se quence of Hsp90 and two ATP-de pend -
ent pro teins – topoisomerase II (DNA gyrase B,
GyrB) and pro tein MutL. Con ser va tive amino acid
res i dues, in volved in ATP bind ing and its hy dro ly sis,
were de fined [9]. The iden ti fi ca tion of key res i dues in
N-ter mi nal struc ture of Hsp90 by the method of mu ta -
gen e sis re vealed that N-ter mi nal do main con tains
ATP-bind ing site (Fig. 2, a) [5, 6]. Sub se quently,
crys tal struc tures have been de ter mined for N-ter mi -
nal do mains of the mam ma lian endoplasmic re tic u lum 
Hsp90 isoform GRP94 [10] and HtpG for Esch e richia
coli [11].
M-do main. Af ter the struc tural anal y sis of N-ter -
mi nal do main of hu man and yeast Hsp90, the crys tal
struc ture of proteolytically re sis tant, so called mid dle
seg ment – M-do main of yeast was in ves ti gated [12].
Its struc ture con sists of a large αβα-sand wich fixed to
N-ter mi nal site of the pro tein, and a small αβα-sand -
wich, bound to C-ter mi nal do main of Hsp90.
αβα-sand wiches are con nected to each other via a
solid ring of α-coil (Fig. 2, b). A big ger αβα-sand -
wich has a fold (curve) sim i lar to the equiv a lent re -
gion of GyrB and pro tein MutL, al though there is a
con sid er able dif fer ence in the re gion in volved in the
in ter ac tion of MutL and GyrB with DNA. A smaller
αβα-do main is unique, though it has ar chi tec tural
sim i lar ity to the big ger, clas sic αβα-do main. The
anal ogy be tween MutL and GyrB was stud ied us ing
site-spe cific mu ta gen e sis [9].
It was re vealed that the mid dle seg ment con tains a
ma jor site of in ter ac tion with “cli ent” pro teins. This is
a small con ser va tive hy dro pho bic site with a Trp300 as
the cen tre and an un usual amphipatic pro tu ber ance,
formed by amino acid res i dues 327–340. The cen tral
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β-sheet of αβα-do main con tains a ly sin, in ter act ing
with γ-phos phate of ATP, bound to N-do main Hsp90
[5]. The method of site-spe cific mu ta gen e sis also re -
vealed con ser va tive Arg380, which is im por tant for
ATP-ac tiv ity of Hsp90 of yeast both in vi tro and in
vivo. M-do main of Hsp90 is also a fac tor, re spon si ble
for dif fer en ti a tion be tween dif fer ent types of cli ent
pro teins [5]. 
C-ter mi nal do main. The crys tal struc ture of
C-ter mi nal do main of Hsp90 homologue, iso lated
from E. coli – HtpG , was firstly an a lyzed (Fig. 2, c)
[13]. C-ter mi nal do main is es sen tial for chap eron
dimerization. C-do main of HtpG is a dimer, con sist -
ing of small αβ-do mains. The com par i son of pri mary
and sec ond ary struc tures of C-ter mi nal do mains of
Hsp90 of prokaryotes and eukaryotes re vealed that the 
most char ac ter is tic fea ture of C-do main of HtpG is the 
ab sence of more than 35 amino acid res i dues in the
ter mi nal seg ment, namely – in MEEVD-mo tive, in -
volved in bind ing with TPR-do main (tetratricopeptide 
re peat do main) [14]. Nev er the less, the gen eral struc -
ture of C-do main of Hsp90 of both eukaryotes and
bac te ria is very sim i lar and as the crys tal struc ture for
eukaryotic Hsp90 is cur rently ab sent, the bac te rial
struc ture of HtpG may serve as an ex am ple of a good
work ing model. Tak ing the above men tioned into con -
sid er ation, we may con clude that the com plete struc -
ture of mo lec u lar chaperone Hsp90 is known in gen -
eral, how ever only on the ba sis of its sep a rate do -
mains. There is one more site, the struc ture of which
has not been stud ied yet. It is the site, lo cated be tween
N- and M-do mains (Fig. 1, a), which is no ta ble for
weak con ser va tism. Both bac te rial HtpG and mi to -
chon drial pro tein do not have this site. Its size is in the
range of 30–70 amino acid res i dues in dif fer ent types
of Hsp90 and isoforms. The ex per i ments in vi tro [15]
and in vivo [16] proved that this seg ment is not cru cial
for Hsp90 func tion ing. 
Conformational changes and ATP-bind ing.
The in hi bi tion of Hsp90 by GA is known to in duce its
deg ra da tion within proteasome. As the chaperone ac -
tiv ity of Hsp90 is de ter mined by the bal ance of ATP
and ADP and the pres ence of pro tein-as sis tants [9],
there is a ques tion how its ATPase ac tiv ity in flu ences
the in ter ac tion with cli ent pro teins. This in ter ac tion
was con sid ered by the au thors of [15] to be
conformational change in the struc ture of Hsp90 – the
tran si tion from the open form into the closed one. The
elec tron mi cros copy dem on strated that while in ter act -
ing with ATP N-ter mi nal do main causes
conformational changes in C-do main: the for ma tion
of a dimer struc ture in which mono mers are ori ented
anti-parallelly to each other in the ab sence of ATP and 
the for ma tion of a ring struc ture in the pres ence of
ATP. At the same time the method of X-ray struc tural
anal y sis of a full-sized HtpG mol e cule [14] dem on -
strated the pres ence of a V-shaped struc ture, form ing
dimers, which is no ta ble for par al lel lo ca tion of mono -
mers. The dif fer ence in con for ma tions shown by elec -
tron mi cros copy of the crys tal struc ture may re flect
con sid er able flex i bil ity of Hsp90 mol e cule in the ab -
sence of ATP-bind ing. It is doubt ful whether this
chaperone mol e cule has the only fixed con for ma tion.
The as so ci a tion of N-ter mi nal do mains was dem on -
strated by sev eral meth ods for Hsp90 from yeast,
chicken, and other eukaryotes. The model of
conformational tran si tions of Hsp90 from the open
form into the closed one in the pro cess of ATP bind ing 
tes ti fies to the fact that the for ma tion of a dimer is nec -
es sary for the hy dro ly sis of ATP, and two halves of
Hsp90 co op er ate with each other to achieve dimer
con for ma tion, ca pa ble of hy dro lys ing ATP [17]. The
stages of achiev ing this con for ma tion are a com plex
struc tural pro cess, in which sev eral ar eas of Hsp90 are 
sub ject to in ter de pen dent re lated trans po si tions, re -
quired for any of two ac tive sites in the dimer to be
cat a lyt i cally ac tive. 
These data are in good agree ment with the re sults
of ki netic anal y sis of Hsp90 of hu mans, which did not
re veal the co op er a tion in clas sic sense be tween
protomers in Hsp90 dimers at ATP hy dro ly sis [18].
The no tion of “func tion ally re lated ATP cy cle” is the
def i ni tion of the pro cess, in which ATP bind ing sta bi -
lizes so called “tense” conformational and func tional
state of Hsp90, de pend ent on the pres ence of γ-phos -
phate of ATP, and the sub se quent hy dro ly sis to ADP
destabilizes the con for ma tion and al lows Hsp90
dimer to re lax [5]. The gen er ally ac cepted model of
the ATP-cy cle is sim i lar to that of dimers GyrB and
MutL, in which N-ter mi nal do mains are lo cated very
close to each other, and each of them is packed tightly
in the di rec tion to wards the mid dle seg ment of the
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same chain. In ATP-bound state DNA-gyrase B forms 
so called mo lec u lar clamp, which is sup posed to close
around the DNA chain, and dur ing ATP hy dro ly sis it
re leases DNA af ter its supercoiling [19, 20]. The pep -
tide binds to the Hsp90 ATP-bind ing cen tre in a sim i -
lar way: it moves in side the chaperone and re leases at
the mo ment of ATP hy dro ly sis [5].
Point mu ta tions in Hsp90, slow ing down ATP hy -
dro ly sis but not in flu enc ing ATP-bind ing, also de -
crease the ef fi ciency of ATP-de pend ent com plex [21]. 
This raises the ques tion: how is the sub strate pro tein
kept in the ATP-cen tre? Al though a space en cir cled
by the Hsp90 dimer is prob a bly too small for an en tire
pro tein sub strate, a siz able do main could be ac com -
mo dated. There is also as sump tion that Hsp90 does
not en close its sub strate but rather that a sub -
strate-bind ing face is op ti mally ex posed by Hsp90 in
the ATP clamp state.
 Re cent in ves ti ga tions have proved the oblig a tory
pres ence of one more nu cle o tide-bind ing site at C-ter -
mi nal do main of Hsp90 [22]. The de le tion of 20 amino 
acid res i dues in C-ter mi nal do main (660–680) de -
stroys bind ing of both ATP and novobiocin. C-do -
main nu cle o tide-bind ing site may get ac ti vated ei ther
when N-ter mi nal site is oc cu pied by a nu cle o tide or is
in ac ti vated, and also when N-site is de leted. On the
other hand, the bind ing of an ti bi otic novomicin to
C-site blocks bind ing of ATP on N-site as well. There -
fore, these two sites, re quired for ATP bind ing, work
in good co or di na tion, which is im por tant for reg u la -
tion of Hsp90 conformational state. A role of this ad -
di tional site is not yet clear, but its in hi bi tion by
novoboicin and cis-plat i num is in ter est ing for fur ther
in ves ti ga tions of its func tion [22]. 
Hsp90 func tions. Hsp90 func tions in vivo as the
main com po nent of the ma jor ity of multi-pro tein com -
plexes; along with other fac tors it is one of the key
reg u la tors of nu mer ous sig nal ing path ways, it par tic i -
pates in pro tein deg ra da tion and per forms also ad di -
tional func tions of con trol, ro ta tion, and trans fer of
var i ous pro teins and sub strates [5].
Nu clear ex port. Many sig nal re sponses of a cell
are the rea son of changes in lo cal iza tion of sig nal ing
pro teins or pro tein kin ases which move and then ac ti -
vate tran scrip tion fac tors, lo cated in the nu cleus.
There is very lit tle data on the move ment of mol e cules 
in side the nu cleus. Pro tein mo bil ity in side the nu cleus 
may be dif fusely lim ited, but it might be at trib uted to a 
spe cific frac tion of res i dent nu clear pro teins only. As
the func tions of nu clear pro teins are of ten lim ited by
spe cific subnucleus com part ments, the sys tem of their 
mo bil ity should be fa cil i tated by a pur pose ful de liv -
ery. Hsp90 reg u lates the ac tiv ity of over 100 pro teins,
in volved in the cell sig nal transduction [23]. These are 
so called “cli ent” pro teins of Hsp90. The cell sig nal
transduction also in volves a multi-pro tein com plex
Hsp90/Hsp70, form ing heterocomplexes of “cli ent”
pro teins and Hsp90 in the cy to plasm and nu cleus.
In case of sig nal ing pro teins, act ing as tran scrip -
tion fac tors, the com plexes of “cli ent” pro teins and
Hsp90 also con tain one or sev eral TPR-do mains of
immunophilins or their homo logues and bind to
TPR-do mains on Hsp90. Dy namic as sem bly of
heterocomplexes and Hsp90 is re quired for fast move -
ment through the cy to plasm to the nu cleus along
microtubular tracks. In this sys tem the role of
immunophilins con sists in con nect ing the “cli ent”
pro tein/Hsp90 com plex to the cy to plas mic dynein – a
mo tor pro tein, pro vid ing the move ment to wards the
nu cleus. Fa cil i tated dif fu sion al lows the move ment of
re cep tor/Hsp90/immunophilin com plexes into the nu -
cleus through the nu clear pore com plex (NPC). Then
non-bound re cep tors spread in the nu cleus, reach ing
the dis crete nu clear cen tres to bind with chromatin.
Ac tive as sem bly of the heterocomplex with Hsp90 is
re quired for the move ment to the nu clear cen tre and
for the ac tive ex change of tran scrip tion fac tors be -
tween chromatin and nucleoplasma.
Ex port of 60S ri bo somal sub unit. Tran si tion of
large sub strates through NPC re quires sig nif i cant
conformational changes in both NPC and a sub strate.
Hsp90 sup ports these struc tural changes [24]. 
It was re vealed that nu clear ex port is pre ferred to
nu clear im port at the con di tions of cel lu lar hy per tro -
phy. In hy per tro phied cells, for in stance, in
cardiomyocytes, the amount of mRNA, de liv ered to
the cy to plasm for pro tein syn the sis, is con sid er ably
in creased [25], the pro tein syn the sis is en hanced,
which should re sult in the in ten si fied syn the sis of ri -
bo somes. It is note wor thy that cardiotrophin-1
(CT-1), which is a fac tor, pro mot ing the stim u la tion
of cardiomyocyte hy per tro phy (it makes the cell grow
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rather than dif fer en ti ate), stim u lates the syn the sis of
Hsp70 and Hsp90 as well. The en hanced syn the sis of
Hsp90 in hy per tro phied cells seems to al low them to
sup port the free nu clear ex port of large sub strates
[26]. The fol low ing model is sug gested for the nu clear 
ex port of 60S ri bo somal sub units. The tran si tion of
60S ri bo somal sub unit through NPC re quires the max -
i mal di la tion of their pores, fa cil i tated by Hsp90 due
to its chaperone func tion. Then Hsp90 fa cil i tates the
tran si tion of 60S ri bo somal sub unit from NPC to
cytoskeleton, “lead ing” the ri bo somal sub unit
through the cell via so called trans port cytoskeleton
route to its fi nal des ti na tion place. It was dem on -
strated ear lier that Hsp90 pro motes the for ma tion of
ri bo somal crys tals in side the nu cleus [28], and the
tran si tion of 60S ri bo somal sub unit through NPC
takes place with the me di a tion of Hsp90. The lat ter
helps the sub strate “to dis solve” in the hy dro pho bic
en vi ron ment of NPC. Tak ing into con sid er ation a
huge size of 60S ri bo somal sub units, their trans port is
a more com pli cated mech a nism, in volv ing more fac -
tors and var i ous in ter ac tions be tween 60S ri bo somal
sub units and NPC than the same pro cesses for such
small sub strates as pro teins and tRNA.
Hsp90 and sig nal transduction. Nu mer ous pro -
teins, which are transduction sig nals in a cell, are main 
sub strates of Hsp90. These pro teins de pend on Hsp90, 
which keeps them in ac tive con for ma tion. Dis or ders
in Hsp90 func tions due to mu ta tions or treat ment with
such in hib i tors as ansamycins cause nu mer ous
changes in the cel lu lar cy cle, which cor re spond to the
con tri bu tion of Hsp90 into the sig nal ing path ways of
the cell. For in stance, point mu ta tion in Hsp90 dur ing
the reg u la tion of cell di vi sion re sults in the change in
many stages of mi totic sig nal ing cas cade, the
centrosomal cy cle in the course of mi to sis [28]. In
vivo ex per i ments re vealed the sig nif i cance of Hsp90
for the func tion ing of ste roid hor mone re cep tors [29],
some ty ro sine and serine/threonine kin ases, such as
pp60/v-src, Wee-1, Cdk4, Raf, and Akt [30] as well as
some pro teins – synthase of ni tro gen ox ide and
calcineurin [31]. These are large and multi-do main
pro teins, the func tion ing of which re quires sta bi liz ing
re la tions with other fac tors, such as lig ands for ste roid 
hor mone re cep tors or cyclins for cyclin-de pend ent
kin ases. As sig nal ing pro teins, hav ing nu mer ous reg u -
la tory func tions, are of ten un der the im pact of
conformational changes, their in ter ac tion with Hsp90
may be the re sult of struc tural changes in these pro -
teins, which fa cil i tate their rec og ni tion by Hsp90.
Hsp90-de pend ent sig nal ing path way of ste roid
hor mone re cep tors is char ac ter ized the most [30]. A
glucocorticoid re cep tor mono mer (GR) and a
progesteron re cep tor are loaded on Hsp90 via
Hsp70/Hor-de pend ent mech a nism, bind to Hsp90 and 
achieve their hor mone-bind ing con for ma tion. As
soon as the folded monomeric re cep tor is free from the 
chaperone, it binds to a cor re spond ing ste roid hor -
mone im me di ately, form ing a dimer and ac ti vat ing it.
A dimer be comes non-sta ble and is rec og nized by a
chaperone again. 
The progesteron re cep tor and GR are used for the
re con struc tion of typ i cal multi-chaperone com plexes
with pu ri fied Hsp90, Hsc70, Hop, and p23 of mam -
mals [32]. Hsp90/Hop/Hsp70/Hsp40 com plex was
called a foldosome. A foldosome con verts GR from
the folded state, in which a ste roid-bind ing site is
closed and thus is not ca pa ble of in ter act ing with the
ste roid, into the open state, ac ces si ble for the ste roid
[33]. While form ing a foldosome Hop binds to Hsp90
and Hsp70 via TPR-do mains. Hop binds a dimer
Hsp90 mol e cule, and chaperone Hsp40 is a
co-chaperone of Hsp70, which is also pres ent in the
tetracomplex and ex e cutes ATP/Mg2+- and K+-de -
pend ent open ing of ste roid-bind ing site. While the
ste roid-bind ing site is open, Hsp90 con verts into
ATP-bound con for ma tion, dy nam i cally sta bi lized by
p23 pro tein, which re sults in re leas ing Hop from
Hsp90. The com plex formed is as sem bled in such a
way that sev eral changes in it are oc cur ring in dy -
namic fash ion. Immunophilins are also con nected to
Hsp90 via TPR-do mains, and when Hop leaves the
com plex, the immunophilin may bind a sin gle
TPR-ac cep tor site on the re cep tor-bind ing Hsp90
dimer. Some Hsp70 pro teins may also form an in ter -
me di ate com plex. 
Al though the func tion of Hsp90, de ter mined by
ATP hy dro ly sis in the course of ste roid hor mone re -
cep tor mat u ra tion, was dem on strated, it is doubt ful in
case of in vi tro con di tions. There is an as sump tion re -
gard ing v-src and other kin ases that Hsp90 sta bi lizes
un pro tected cat a lytic do mains prior to as sem bling the
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kinase into the fi nal sig nal ing com plex. This mech a -
nism is con cep tu ally re lated to the ste roid re cep tor
path way. The vari ant of the sig nal ing path way of
ecdysone ste roid re cep tor (EcR – re cep tor of fam ily of 
heterodimeric retinoid X) was de scribed for
Drosophila. Along with the pro tein part ner USP, the
iso lated re cep tor is ready to bind to EcR rather than to
DNA, and Hsp90 con verts a hor mone-bound re cep tor
into the ac tive DNA-bind ing state [34]. 
There is one more mech a nism of in ter ac tion,
which al lows hu man Hsp90 reg u late its own ex pres -
sion by means of iso la tion of monomeric in ac tive
form of HSF1 (heat shock tran scrip tion fac tor) at
non-stress con di tions [35], when dis or derly placed
pro teins, formed as a re sult of stress ful con di tion, may 
com pete with HSF1 for bind ing to Hsp90, thus re leas -
ing the tran scrip tion fac tor for trimerization and ini ti -
a tion of heat shock re sponse. 
GR is an exellent model for the study on nu -
cleus-cy to plas mic trans fer of the tran scrip tion fac tor
from the cy to plasm to the nu cleus, as it is usu ally lo -
cated in the cy to plasm of cells, free from the hor mone, 
and its fast tran si tion to the nu cleus is hor mone-de -
pend ent. It was re vealed that GRs were con stantly
mov ing be tween the cy to plasm and the nu cleus, thus
they sup port nu cleus ac cu mu la tion of GR/Hsp90
com plex via ligand-de pend ent trans for ma tion [36].
The tran si tion of GR takes place along with Hsp90
move ment. The trans for ma tion, de pend ent on the
ligand, con verts the re cep tor from the state of form ing
a “sta ble” com plex with Hsp90 into the state when
GR/Hsp90 com plex is more ac tive in the cy cle of its
ac cu mu la tion and dissimilation. A more ac tive com -
plex is re quired for fast move ment of the re cep tor. The 
model of ret ro grade tran si tion of GR with the help of
dynein along cytoskeleton tracks was first sug gested
in 1993 [37]. Re cent years have wit nessed a con sid er -
able im prove ment of this model. As of date, it is
known that some Hsp90-bound immunophilins are
bound by peptidyl-prolyl-isomerase (PPIase) do -
mains with the cytosplasmatic dynein. The com plex
was iso lated from the cells and re con structed in a
cell-free sys tem [38]. The tran si tion of GR and sev eral 
other tran scrip tion fac tors from the cy to plasm into the 
nu cleus is ei ther slowed down or blocked by Hsp90
in hib i tors, co-ex pres sion of the frag ment of
PPIase-do main, block ing the bind ing of
immunophilin to dynein and co-ex pres sion of
dynamitin, which causes the dis so ci a tion of dynein
and its “load”. There fore, the ob vi ous proofs were ob -
tained in vivo to sup port the model of GR tran si tion.
Con trary to the pen e tra tion of pro teins into mi to -
chon dria and other organelles, where pro teins should
be un folded to pass, their tran si tion through NPC does 
not in flu ence the na tive state due to a con sid er able
size of pores enough for rather large multimeric com -
plexes – (1–3)·106 Da [38]. As soon as sig nal ing pro -
teins ap proach the nu cleus mem brane, they get into
the pores via fa cil i tated dif fu sion. Cur rently the pref -
er ence is given to the model of re cep -
tor/Hsp90/immunophilin com plex for trans fer
through nu clear pores [39]. In fact nei ther Hsp90 nor
Hsp90-bound immunophilins have their own nu clear
lo cal iza tion sig nals (NLS). They are pres ent in the nu -
cleus due to their at ten dant trans fer via nu mer ous
NLS-con tain ing “cli ent” pro teins.
The in ter ac tion of nu clear pro teins with sol u ble
part ners or the ones in ag gre gate state re sults in a con -
sid er able im pair ment of their mo bil ity [40]. Spe cific
nu clear com part ments of ten gov ern the func tions of
nu clear pro teins. In par tic u lar, the au thors of [41,42]
dem on strated the tran si tion of pro teins from the nu -
cleus along the tracks through the pores, but the na ture 
of threads (who plays a role of nu clear actin?) and po -
ten tial mov ing mo tor pro teins (a role of nu clear my o -
sin?) is yet to be dis cov ered. The ovary cells of Chi -
nese ham ster were used to dem on strate that ex pressed
nu clear GR FKBP52 and hor mone-free GR are lo -
cated in the same loci of the nu cleus. Sim i lar lo cal iza -
tion is in good agree ment with the as sump tion that
FKBP52 moves to the tar get along the sug gested
“stag ing ar eas” in side the nu cleus at least.
There are ev i dences to the fact that GR/Hsp90
com plex is nec es sary for the hor mone fix a tion, that is
also proven by the abil ity of the re cep tor to re cy cle in
the GR/Hsp90 com plex in side the nu cleus. The same
cy cle in the nu cleus was dem on strated in DeFranko
lab o ra tory [43]. It was re vealed that GR, re leased
from chromatin, may re peat edly be used n in the pro -
cess of bind ing the hor mone with out exit out of the
nu cleus. Geldanamycin in hib its re peated use of the
hor mone and thus in hib its the re lease of GR from
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chromatin. It is in agree ment with the role of
Hsp90/Hsp70 com plex in the ter mi na tion of tran scrip -
tion ac tiv ity in case of de crease in the level of the free
hor mone. In situ sys tem was used to dem on strate the
dis place ment of the re cep tor within the nu cleus on the
model of pu ri fied Hsp90/Hsp70 com plex. Af ter the
dis so ci a tion of the hor mone [H] GRs are re leased
from bind ing sites on chromatin. How ever, there is
still a ques tion on the time of trans for ma tion of GR
dimer into a mono mer: does it hap pen while the re cep -
tor is bound to chromatin or when it makes a com plex
with Hsp90? The stehiometry of the fi nal
heterocomplex is one GR mol e cule, bound to Hsp90
dimer [44]. Hop co-chaperone or ga nizes all the
chaperones, par tic i pat ing in this pro cess, into one
com plex – Ísp90/Hop/Ísp70/Ísp40. When
ATP-bind ing cen tre of GR/Hsp90 com plex is in ac -
tive con for ma tion, GR re turns to its bind ing state, and
p23 in ter acts with Hsp90 to sta bi lize the com plex. Nu -
clear GR, used re peat edly in GR-Hsp90-p23 com plex, 
may in ter act with the hor mone not leav ing the nu cleus 
and then par tic i pate in bind ing again. 
p23 com po nent is of im por tant in stru ment in the in -
ves ti ga tion on the role of Hsp90 in the course of tran -
scrip tion com plex dis as sem bly and in the study on re -
peated bind ing of the re cep tor in the nu cleus. In vi tro
ex per i ments dem on strated two mech a nisms of p23 ac -
tion [24]. The ex per i ments on GR/Hsp90 as sem bly
dem on strated that p23 acts as co-chaperone Hsp90 and
in ter acts with GR/Hsp90 com plex as soon as it is
formed, thus sta bi liz ing it. p23 may also act as a
chaperone, in hib it ing the ag gre ga tion of denaturated
pro teins and keep ing them in folded state. In vivo ex -
per i ments showed the par tic i pa tion of p23 in the sta bi -
li za tion of chaperone com plex Hsp90/Hsp70 [44].
There are also nu mer ous ev i dences to the fact that as a
part of heterocomplex Hsp90 is in volved in the pro cess
of tran si tion of transcriptional fac tors, which are “cli ent” 
pro teins of Hsp90, along the cy to plasm and nu cleus. 
Hsp90 and pro tein deg ra da tion. A visit card of
the ac tiv ity of ansamycin in liv ing cells is the in duc -
tion of deg ra da tion of sub strate pro teins by Hsp90
chaperone us ing ubiquitin-proteasome path way.
Though his tor i cally ansamycins were dis cov ered as
in hib i tors of ty ro sine kin ases, they are cur rently
known as in hib i tors of Hsp90. Ansamycins are ca pa -
ble of in hib it ing chaperone-me di ated fold ing of
Hsp90 sub strates, thus block ing their dis as sem bly
from Hsp90. On the other hand, some sub strate pro -
teins are re leased by ansamycin from the com plex
with Hsp90 [45,46]. 
In what way do Hsp90-bound pep tides serve as a
deg ra da tion tar get? TPR co-chaperone CHIP, ca pa ble
of rec og niz ing both chaperones (hsp90 and Hsc70),
con tains a so called U-do main, which is ho mol o gous
to E4-ubiquitin fac tors, and may pres ent
chaperone-bound non-placed pro teins for
ubiquitination. There fore, super-ex pres sion of CHIP
in cul ti vated cells re sults in the in crease in
ubiquitination and deg ra da tion of GR and
transmembrane reg u la tor of mucoviscidosis of CFTR, 
which are the sub strates of Hsp90 and Hsc70. CHIP
ac tiv ity is re quired for the ki net ics of pro tein fold ing
and deg ra da tion. Due to this ac tiv ity the sub strates in -
ter act with Hsp90 lon ger, for in stance as a re sult of in -
hib it ing ATP-cen tre for their fur ther ubiquitination.
The ex is tence of CHIP al lows the as sump tion that
sim i larly to pro tein fold ing the deg ra da tion of pro -
teins is reg u lated by ad di tional fac tors [45].
Re cent stud ies dem on strated [47] that Hsp90 is
bound di rectly to ri bo somal pro tein S3 (rpS3). Due to
the for ma tion of Hsp90/rpS3 com plex the ri bo somal
pro tein rpS3 is pro tected from ubiquitination and
proteasome deg ra da tion, which al lows it to keep its
func tion in biogenesis of the ri bo some later. Hsp90 in -
hib i tors in flu ence the dis as sem bly of rpS3 from
Hsp90, fur ther as so ci a tion of the pro tein and Hsp70
and the in duc tion of its deg ra da tion. It was also re -
vealed that the ri bo somal pro tein S6 (rpS6) in ter acts
with Hsp90 as well, and chaperone in hib i tors have
sim i lar in flu ence on its dis as sem bly from Hsp90 and
fur ther deg ra da tion. There fore, there are grounds for
the as sump tion that Hsp90 reg u lates the func tion of ri -
bo somes via sup port ing the sta bil ity of 40S ri bo somal
pro teins, for in stance of rpS3 and rpS6.
Cardioprotection and phar ma co log i cal prop -
erty of Hsp90. The ex per i ments on the cul ture of
cardiomyocytes dem on strated that Hsp90 sta bi lizes
the pro tein ErbB2 [48,49] which is a vi tal com po nent
of GPCR-sig nal ing path way of cardiomyocytes. The
ex per i ments on mice, per formed to in ves ti gate the in -
flu ence of doxorubicin, the in hib i tor of can cer cells,
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dem on strated that Hsp90 is re spon si ble for the sta bi li -
za tion of ErbB2 in the heart. The in crease in the quan -
tity of ErbB2 in the heart in re sponse to some dam age
may be an im pulse to the sur vival of cells. How ever,
the dam age ex ceed ing the thresh old level (high con -
cen tra tions of doxorubicin) can not be pre vented by
the ac ti va tion of ErbB2 or Akt. It is note wor thy that
the in crease in the con cen tra tion of ErbB2 (along with 
fur ther ac ti va tion of GRCR-sig nals) takes place prior
to ob vi ous im pair ments of sys tolic func tion of the
heart. Such change in ErbB2 con tent may be used in
the di ag nos tics of pa tients, who re ceive the treat ment
with anti-ErbB2 in the case of breast can cer, and who
have a risk of de vel op ing heart symp toms.
Doxorubicin is the in hib i tor, en hanc ing the dis as sem -
bly of ErbB2 and Hsp90, which re sults in the deg ra da -
tion of ErbB2 pro tein. The treat ment of can cer of
suck ling gland leads to the in creased level of the ex -
pres sion of Hsp90 and Hsp70 in the heart. Ox i da tive
dam age of the myocardium, in duced by the stress, in -
flu ences the ex pres sion of Hsp90 in vivo. Be sides
doxorubicin, cyclosporin A [50] also in duces in vivo
ex pres sion of Hsp90 in the heart, which is re lated to
the mod u la tion of en do the lial NO-synthase sig nal ing
path way. It is ev i dent that the search for novel
anticancer treat ment should in clude the es ti ma tion of
their pos si ble side ef fects in vivo, namely, their in flu -
ence on the level of Hsp90 in the cell, in par tic u lar, in
cardiomyocytes.
The superexpression of Hsp90 in the ischemic
stage of car diac in farc tion may pro tect the car diac mus -
cle from ischemia-reperfusion di la tion due to the stim -
u la tion of the NO en do the lial path way [51]. The cul -
ture of en do the lial cells was used to dem on strate the as -
so ci a tion of cardio-pro tec tive ac tiv ity of Hsp90 and its
abil ity to in ter act with the kinase Akt and
calcineurin-phosphatase as an adapter, pro mot ing both
phosphorilation of Ser1177 and de-phosphorilation of
Thr495 eNOS-synthase (en do the lial ni tric ox ide
synthase). Hsp90 is a prom is ing tar get for in creas ing
the for ma tion of eNOS in vivo, which may be ef fi cient
in re spect of de creas ing the level of myo car -
dial/reperfusion in jury.
A role of Hsp90 in the reg u la tion of apoptosis is
rather am big u ous and de pends on apoptotic stim uli,
usu ally ex pos ing anti-apoptotic ac tiv ity. The for ma -
tion of Akt-Hsp90 com plex in vivo sta bi lizes the ac -
tiv ity of Akt kinase and pro tects the cells from
apoptosis, pre vent ing the dephosphorylation of Akt
[30]. Kin ases Raf-1 and MEK par tic i pate in such im -
por tant cel lu lar pro cesses as pro lif er a tion, dif fer en ti a -
tion, and apoptosis, and are vi tal par tic i pants of
pathogenesis of cardiohypertrophy and car diac de fi -
ciency [52]. Hsp90 was found in the as so ci a tion with
many com po nents and reg u la tors of the Raf-1/MEK
sig nal ing in Hsp90 mol e cule of Drosophila sup press
the ac tiv ity of Raf-1 and de crease the af fin ity be tween 
Hsp90 and Raf-1. Geldanamycin also in hib its the for -
ma tion of Raf-1/Hsp90 com plex and causes the deg ra -
da tion of Raf-1. The ac ti va tion of Raf-1 kinase pre -
vents the apoptosis of cardiomyocytes [52]. Hsp90
alone or in the com plex with Hsp70 binds Apaf-1 and
pre vents the for ma tion of Apaf-1 com plex with
cytochrome C, thus be ing a neg a tive reg u la tor of
CytC-me di ated apoptosis. Tak ing the
abovementioned into con sid er ation, one may as sume
that Hsp90 takes an ac tive part in pre vent ing the
apoptosis of cardiomyocytes.
The pro cess of for ma tion of new myofibrils oc curs 
dur ing the en tire pe riod of or gan ism de vel op ment. It
is well known that cardiomyocytes do not di vide, but
they are ca pa ble of re spond ing to in creas ing
hemodynamic load, en larg ing the weight and ca pac ity 
of the con trac tile ap pa ra tus. Such hy per tro phy of the
heart may oc cur both in nor mal con di tions (for in -
stance, in sports men with high phys i cal strain) and at
heart dis eases of dif fer ent eti ol ogy. In the most com -
pli cated forms the growth of heart tis sue re sults in the
de crease in the size of its cham bers, de crease in the
vol ume of pumped out blood and is dan ger ous for the
life of a pa tient [54]. 
It is known that Hsp90 and Hsc70 are bound by
my o sin, form ing a multimeric com plex of my o sin
threads. The half-life of this com plex is short. It is ac -
cu mu lated in case of in hib it ing Hsp90 with
geldanymicin or due to other rea sons, post pon ing the
as sem bly of myofibrils. The cardiomyocyte seems to
launch the same mech a nism of hy per tro phy as in the
case of em bry onic pe riod when the syn the sis of
myofibrils takes place de pend ing on reg u la tory pro -
teins. The in hi bi tions of biosynthesis of these reg u la -
tory com po nents stops the as sem bly of myofibrils.
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As it was al ready men tioned above, the ac tiv ity of
Hsp90 (sim i lar to other chaperones) is reg u lated and
mod u lated via the in ter ac tion with adap tor pro teins
and co-chaperones, for in stance, p23 or re cently dis -
cov ered Sgt1 [55] and melusin [56, 57]. It was found
out that Sgt1 is pres ent in var i ous cells and tis sues of
mam mals, in clud ing the skel e tal and mus cle parts,
and melusin is syn the sized only in the skel e tal and
heart tis sues. The in ter ac tion of Sgt1 and
Hsp90/Hsp70 is mod u lated by S100A6 pro tein via
Ca2+-de pend ent path way, which may be a sig nif i cant
mo ment in the de vel op ment of apoptosis, de pend ing
on intracellular con cen tra tion of cal cium. 
Re cent stud ies have shown that melusin is a new
com po nent – co-chaperone of Hsp90, ca pa ble of pro -
tect ing the ci trate synthase (CS) from ag gre ga tion,
pos si bly due to heat shock [58]. It is also note wor thy
that in hib i tors of Hsp90 are inductors of chap er ons
syn the sis, in par tic u lar, of Hsp90 it self. The syn the sis
of chaperones in the cell is in duced by HSF-1. Hsp90
dis so ci ates from HSF-1 at the mo ment of its ac ti va tion 
due to com pet ing bind ing of un folded pro teins [59].
The in hib i tors of Hsp90 pro mote the tran scrip tion ac -
tiv ity of HSF-1 due to the de struc tion of Hsp/HSF-1
com plex, as a re sult HSF-1 re leases and translocates
into the nu cleus, phos phory lates and binds to HSE,
thus in duc ing the tran scrip tion of genes hsp40, hsp70,
and hsp90. In par tic u lar, due to bind ing of Hsp90 the
in hib i tor radicicol ac ti vates the tran scrip tion of genes
of chaperones in the cells of neo na tal cardiomyocytes
of rats.
There fore, Hsp90 mod u lates the level of
cardioprotection of cardiomyocytes, thus reg u lat ing
the ex pres sion of Hsp90 di rectly via its abil ity to bind
HSF-1 [60]. In cardiomyocytes the ex pres sion of
Hsp90 and cardioprotection are mod u lated by the
amount of Hsp90. The ap pli ca tion of non-toxic de riv -
a tives of radicicol may be come one of the stages of de -
vel op ing ther a peu tic means for the treat ment of car -
dio vas cu lar dis eases.
The in tro duc tion of the gene hsp90 into the
myocardium [51] pre vents ischemic cardiomyopathy
in pigs and stim u lates the syn the sis of eNOS by
chaperone Hsp90. It is well-known that NO has a
cardio-pro tec tive func tion, but at the same time the in -
crease in the level of its syn the sis re sults in ap pear -
ance of cytotoxic peroxynitrites with superoxide rad i -
cals, which dam age tis sues. Pro longed pro duc tion of
NO, de ter mined by the ac cu mu la tion of tu mour
growth sup pres sor p53, re sults in apoptosis. 
Re gard less of the fact that superoxide an ion also
in duces apoptosis, the bal ance of NO and superoxide
an ion re sults in cross-pro tec tive ef fect and the pro cess 
of apoptosis is con sid er ably in hib ited [61]. The in ves -
ti ga tion of the func tions of mo lec u lar chaperone
Hsp90, one of which is cardioprotection, and the es ti -
ma tion of pos si ble role of in hib i tors of Hsp90 in this
func tion, makes this pro tein a prom is ing tool of
cardio-vas cu lar ther apy.
². Â. Êðó ïñüêà
Ìî ëå êó ëÿðíèé øà ïå ðîí Hsp90: ñòðóê òó ðà, ôóíêö³¿ òà ó÷àñòü ó
êàðä³îâàñ êó ëÿðí³é ïà òî ëîã³¿
Ðå çþ ìå
Îãëÿä ïðè ñâÿ ÷åíî àíàë³çó ñòðóê òóð íèõ ³ ôóíêö³îíàëü íèõ âëàñ -
òè âîñ òåé ìî ëå êó ëÿð íî ãî øà ïå ðî íó Hsp90. Hsp90 º ïðåä ñòàâ -
íè êîì øè ðî êî ðîç ïîâ ñþä æå íî¿ ðî äèíè á³ëê³â òåïëîâîãî øîêó.
Éîãî çíàé äåíî â áàê òåð³ÿõ òà â åó êàð³îòàõ, àëå â³í â³äñóòí³é â
àð õå áàê òåð³ÿõ, º îäíèì ³ç êëþ ÷î âèõ ðå ãó ëÿ òîð³â áà ãà òî ÷è ñåëü -
íèõ ñèã íàëü íèõ øëÿõ³â, ÿê³ îáóìîâëþþòü ð³ñò ³ ðîç âè òîê êë³-
òèí, àïîï òîç, ³íäóêö³þ àâòî³ìóí íèõ ïðî öåñ³â ³ ïðî ãðåñ³þ ñåð -
öå âî¿ íå äîñ òàò íîñò³. Ïîâ íà ôóíêö³îíàëü íà àêòèâí³ñòü öüî ãî
á³ëêà âèÿâëÿºòüñÿ ó êîì ïëåêñ³ ç ³íøè ìè ìî ëå êó ëÿð íè ìè øà ïå ðî -
íà ìè òà êîøà ïå ðî íà ìè. Ìî ëå êó ëÿðí³ âçàºìîä³¿ ì³æ øà ïå ðî íà -
ìè, ð³çíî ìàí³òíè ìè ñèãíàëü íè ìè á³ëêà ìè ³ á³ëêà ìè-ïàðò-
íå ðà ìè êðè òè÷í³ äëÿ íîð ìàëü íî ãî ôóíêö³îíó âàí íÿ ñèã íàëü íèõ
øëÿõ³â, à ¿õíº ïî ðó øåí íÿ ïðè çâî äèòü äî çì³í ó ô³ç³îëîã³¿
êë³òèíè ³ íàâ³òü äî ¿¿ çà ãè áåë³.
Êëþ ÷îâ³ ñëî âà: Hsp90, äî ìåí, êðèñ òàë³÷íà ñòðóê òó ðà, ñèã -
íàëü íèé øëÿõ, àïîï òîç.
È. Â. Êðóï ñêàÿ 
Ìî ëå êó ëÿð íûé øà ïå ðîí Hsp90: ñòðóê òó ðà, ôóíê öèè è ó÷àñ òèå
â êàð äè î âàñ êó ëÿð íîé ïà òî ëî ãèè
Ðå çþ ìå
Îáçîð ïî ñâÿ ùåí àíà ëè çó ñòðóê òóð íûõ è ôóíê öè î íàëü íûõ
ñâîéñòâ ìî ëå êó ëÿð íî ãî øà ïå ðî íà Hsp90. Hsp90 ÿâ ëÿ åò ñÿ ïðåä -
ñòà âè òå ëåì øè ðî êî ðàñ ïðîñ òðà íåí íî ãî ñå ìå éñòâà áåë êîâ
òåï ëî âî ãî øîêà. Îí îá íà ðó æåí â áàê òå ðè ÿõ è â ýó êà ðè î òàõ, íî
îò ñó òñòâó åò â àð õå áàê òå ðè ÿõ, ñëó æèò òàê æå îäíèì èç êëþ -
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÷å âûõ ðå ãó ëÿ òî ðîâ ìíî ãî ÷èñ ëåí íûõ ñèã íàëü íèõ ïó òåé, îïðå äå -
ëÿ þ ùèõ ðîñò è ðàç âè òèå êëå òîê, àïîï òîç, èí äóê öèþ
àó òî èì ìóí íûõ ðå àê öèé è ïðî ãðåñ ñèþ ñåð äå÷ íîé íå äîñ òà òî÷ -
íîñ òè. Ïîë íàÿ ôóíê öè î íàëü íàÿ àê òèâ íîñòü ýòî ãî áåë êà ïðî -
ÿâ ëÿ åò ñÿ â êîì ïëåê ñå ñ äðó ãè ìè ìî ëå êó ëÿð íè ìè øà ïå ðî íà ìè è
êî øà ïå ðî íà ìè. Ìî ëå êó ëÿð íûå âçà è ìî äå éñòâèÿ ìåæ äó øà ïå ðî -
íà ìè, ðàç ëè÷ íû ìè ñèã íàëü íû ìè áåë êà ìè è áåë êà ìè-ïàð òíå ðà -
ìè êðè òè÷ íû äëÿ íîð ìàëü íî ãî ôóíê öè î íè ðî âà íèÿ ñèã íàëü íûõ
ïó òåé, à íà ðó øå íèå èõ âû çû âà åò èç ìå íå íèÿ â ôè çè î ëî ãèè êëåò -
êè âïëîòü äî åå ãè áå ëè. 
Êëþ ÷å âûå ñëî âà: Hsp90, äî ìåí, êðèñ òàë ëè ÷åñ êàÿ ñòðóê òó -
ðà, ñèã íàëü íûé ïóòü, àïîï òîç.
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